| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/01/2007 | WO2006113220A9 Transgenic mammals expressing human preproinsulin |
| 03/01/2007 | WO2006110589A8 Gammaretrovirus associated with cancer |
| 03/01/2007 | WO2006105329A3 Device for evaluating in vitro cell migration under flow conditions, and methods of use thereof |
| 03/01/2007 | WO2006095342A3 Natural tissue-derived decellularized matrix and methods of generating and using same |
| 03/01/2007 | WO2006090388A3 Fruit cell culture extract for treating inflammation |
| 03/01/2007 | WO2006090291A3 Method for expanding cd4+ cd25+ t regulatory cells |
| 03/01/2007 | WO2006088481A3 Genetically engineered equine influenza virus and uses thereof |
| 03/01/2007 | WO2006081573A3 Homogeneous preparations of il-31 |
| 03/01/2007 | WO2006076251A3 Efficient gene suppression using a transfer rna promoter in herpes virus vectors to deliver small interference rnas |
| 03/01/2007 | WO2006076032A3 Alphavirus replicon packaging constructs |
| 03/01/2007 | WO2006075187A3 Animals exhibiting an altered preference for an addictive substance |
| 03/01/2007 | WO2006072016A3 Methods for regulation of stem cells |
| 03/01/2007 | WO2006071777A3 Soft tissue repair and regeneration using postpartum-derived cells and cell products |
| 03/01/2007 | WO2006061723B1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 03/01/2007 | WO2006053110A3 Ovr110 antibody compositions and methods of use |
| 03/01/2007 | WO2006052835A3 Cryopreservation of cells |
| 03/01/2007 | WO2006014526A3 Compositions and methods relating to novel compounds and targets thereof |
| 03/01/2007 | WO2006010020A3 T cell hybridomas |
| 03/01/2007 | WO2004081032A3 Novel litaf binding site peptides and methods of using the same |
| 03/01/2007 | WO2003080675A3 MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13Rα1) |
| 03/01/2007 | US20070050869 Regulatory sequences useful for production of plants with modified embryo and/or endosperm development |
| 03/01/2007 | US20070050868 Agents for phytoremediation |
| 03/01/2007 | US20070050867 Methods of modulating cytokinin related processes in a plant using B3 domain proteins |
| 03/01/2007 | US20070050866 Control of hypocotyllength and flowering time by COL8 gene |
| 03/01/2007 | US20070050865 Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same |
| 03/01/2007 | US20070050864 Rubisco activase with increased thermostability and methods of use thereof |
| 03/01/2007 | US20070050863 Herbicide Resistance Gene, Compositions and Methods |
| 03/01/2007 | US20070050862 Promoter and methods of use in plants |
| 03/01/2007 | US20070050861 Seeds and plants produced by crossing the inbred line GKO-1 with itself or another broccoli line; insect resistance, herbicide resistance, male sterility, disease resistance |
| 03/01/2007 | US20070050859 Selecting a codon of a parent polynucleotide that encodes a polypeptide for replacement with a synonymous codon, replacing the codon with synonymous codon (corresponds to an iso-tRNA ) to form a synthetic polynucleotide and introducing into a mammal cell |
| 03/01/2007 | US20070050858 Inactive ca2+/calmodulin-dependent protein kinase II-alpha knockin animal and knockin cell of the same |
| 03/01/2007 | US20070050857 Method of treatment and prophylaxis |
| 03/01/2007 | US20070050856 Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 03/01/2007 | US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/01/2007 | US20070049730 for treatment of disorders which are mediated at least in part by Hedgehog (Hh) especially Desert hedgehog (Dhh) in particular testicular cancer |
| 03/01/2007 | US20070049544 Antisense IAP nucleobase oligomers and uses thereof |
| 03/01/2007 | US20070049526 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton |
| 03/01/2007 | US20070048865 Method for acceleration of stem cell differentiation |
| 03/01/2007 | US20070048864 Propagating progenitor cell line from cell isolated from inner cell mass tissues; in vitro fertilization |
| 03/01/2007 | US20070048863 Computerized factorial experimental design and control of reaction sites and arrays thereof |
| 03/01/2007 | US20070048847 Methods of producing antibodies to cytokine receptor |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection |
| 03/01/2007 | US20070048840 Human Zven polynucleotides |
| 03/01/2007 | US20070048839 Novel amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 03/01/2007 | US20070048828 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 03/01/2007 | US20070048825 Compositions and methods for the diagnosis and treatment of tumor |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048780 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines |
| 03/01/2007 | US20070048778 determining the amount of a polynucleotide sequence or a fragment of at least 20 consecutive nucleotides in a test sample and comparing the amount with that from a control, wherein an increase indicates a gastrointestinal disorder |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048729 Method of creating a collection of biological specimens, and collection of specimens |
| 03/01/2007 | US20070048381 Methods for promoting growth of bone, ligament, and cartilage |
| 03/01/2007 | US20070048324 Antibody which binds fetal thymocytes, inhibitits cell proliferation and does not bind adult thymocytes; for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/01/2007 | US20070048313 Hybridoma cell lines and monoclonal antibodies recognizing Prox1 |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | US20070048310 Human ataxin-1-like polypeptide IMX97018 |
| 03/01/2007 | US20070048304 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain |
| 03/01/2007 | US20070048302 Interleukin-2 (IL-2); treating metastatic cancer, autoimmune disorders, and viral infections such as HIV by administering a peptide that peptide binds to the IL-2 beta chain |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048293 Manipulation of PTEN in T cells as a strategy to modulate immune responses |
| 03/01/2007 | US20070048292 Cell-containing sheet |
| 03/01/2007 | US20070048291 Method and material for enhanced tissue-biomaterial integration |
| 03/01/2007 | US20070048290 Development of natural killer cells and functional natural killer cell lines |
| 03/01/2007 | US20070048288 Shear thinning polymer cell delivery compositions |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | US20070048258 Use of human Zven proteins and polynucleotides |
| 03/01/2007 | DE102004047965B4 Kryoeinrichtung und zugehöriges Betriebsverfahren Cryoapparatus and operating method thereof |
| 03/01/2007 | CA2620210A1 Plant producing hyaluronic acid |
| 03/01/2007 | CA2619916A1 Methods and complexes for determining cell culture history |
| 03/01/2007 | CA2618731A1 Decellularization and recellularization of organs and tissues |
| 03/01/2007 | CA2618203A1 System for screening cells for high expression of a protein of interest (poi) |
| 03/01/2007 | CA2615761A1 Humanized anti-ca6 antibodies and methods of using the same |
| 03/01/2007 | CA2606402A1 Nanoscale neuromodulating platform for retina neuron activation apparatus and method |
| 02/28/2007 | EP1757700A2 Cell culture process for glycoproteins |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757685A1 Modified ethylenediamine-n,n' disuccinic acid:ethylenediamine lyase |
| 02/28/2007 | EP1757684A2 A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme |
| 02/28/2007 | EP1757683A1 Method of making a mutated type IIT endonuclease which has nicking activity |
| 02/28/2007 | EP1757682A1 Es cell mutation method and system |
| 02/28/2007 | EP1757681A1 Tolerizing allografts of pluripotent stem cells |
| 02/28/2007 | EP1757680A1 Adoptive immunocyte for tumor vaccine and the like |
| 02/28/2007 | EP1757662A2 Method for the production of highly organized crystals by means of sol-gel methods |
| 02/28/2007 | EP1757622A1 Bivalent IgY antibody constructs for diagnostic and therapeutic applications |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757616A2 Semaphorin receptors |
| 02/28/2007 | EP1757314A1 Functionalized derivatives of hyaluronic acid, formation of hydrogels and in situ using same |
| 02/28/2007 | EP1757307A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation |
| 02/28/2007 | EP1757302A1 Adiponectin expression inducer and utilization of the same |
| 02/28/2007 | EP1757295A1 Peripheral-Type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |